Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
about
Management of women with multiple sclerosis through pregnancy and after childbirthUse of natalizumab in multiple sclerosis: current perspectives.Natalizumab in relapsing-remitting multiple sclerosis.Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.
P2860
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
@en
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
@nl
type
label
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
@en
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
@nl
prefLabel
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
@en
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
@nl
P2093
P2860
P356
P1476
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
@en
P2093
Amandine Benoit
Bernard Frangoulis
Christian Confavreux
Françoise Durand-Dubief
Romain Marignier
Sandra Vukusic
P2860
P304
P356
10.1177/1352458514554056
P577
2014-10-10T00:00:00Z